Boehringer Ingelheim
Arup Pramanik MD, MSc, MBA has a diverse and extensive work experience in the pharmaceutical industry. Arup has held various leadership positions and has been involved in global market access, strategic planning, and value optimization for pharmaceutical companies. Arup has worked with leading companies such as Boehringer Ingelheim, Indivior, Ipsen, Shire, Novartis, and Pfizer. Their roles have focused on commercializing life-changing therapies, supporting innovation in healthcare systems, and implementing access and value models globally. Arup has also led teams, developed internal capabilities, and collaborated with stakeholders to enhance patient-centric solutions. Arup's expertise lies in market access, health economics, policy, and strategic planning.
Arup Pramanik MD, MSc, MBA completed their education history with the following degrees: a Master of Science (MSc) in Health Economics, Policy & Management from The London School of Economics and Political Science (LSE) from 2011 to 2013, a Fellow College of Physicians (FCGP) in Internal Medicine from 1992 to 2006, a Master's Degree in Internal Medicine from the University of Aberdeen from 2002 to 2004, a Doctor of Medicine (M.D.) from The Royal College of Physicians of Ireland from 1994 to 1998, and a Doctor of Medicine (MD) in Medicine & Surgery from Nagpur University from 1984 to 1988. Arup also holds an MBA in Marketing/Marketing Management, General from Preston U, although the start and end years for this degree are not provided.
This person is not in any offices
Boehringer Ingelheim
108 followers
At Boehringer Ingelheim they create value through innovation with one clear goal: to improve the lives of patients. They develop breakthrough therapies and innovative healthcare solutions in areas of unmet medical need for both humans and animals. As a family owned company, they focus on long-term performance. They are powered by 50.000 employees globally who nurture a diverse, collaborative and inclusive culture. Learning and development for all employees is key, because your growth is their growth.